CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The firm is also involved in developing innovative therapeutics addressing cancer and other unmet medical needs for the global market. The company was founded in 1991 and is headquartered in Beijing, China.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
214
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. CASI Pharmaceuticals Inc market cap is $2.26M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. CASI Pharmaceuticals Inc 52 week high is $1.24 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. CASI Pharmaceuticals Inc 52 week low is $0.05 as of November 22, 2026.
CASI Pharmaceuticals Inc stock price today is $0.1099.
CASI Pharmaceuticals Inc stock price yesterday was $0.10.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. CASI Pharmaceuticals Inc's P/E ratio is -0.04.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. CASI Pharmaceuticals Inc P/B ratio is -0.0388.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. CASI Pharmaceuticals Inc 50-day moving average is $0.1116.